Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 4/2014

01-04-2014 | Urology - Case Report

Calcular pulmonary embolism

Authors: Mohamed H. Zahran, Yasser Osman, Tarek EL-Diasty

Published in: International Urology and Nephrology | Issue 4/2014

Login to get access

Abstract

Many complications of percutaneous nephrolithotomy (PNL) were reported. In this report, we present a rare complication, which has never been reported. It is the migration of stone fragments into the venous system causing pulmonary emboli. We reviewed the literatures reporting complications following PNL, and there was no available previous report about such complication. It was suspected intraoperative and confirmed radiologically postoperative. In this case, pulmonary emboli have had no clinical consequences and were managed conservatively.
Literature
1.
Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr (2005) AUA nephrolithiasis guideline panel. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173:1991–2000PubMedCrossRef
2.
El-Nahas AR, Shokeir AA, El-Assmy AM, Mohsen T, Shoma AM, Eraky I, El-Kenawy MR, El-Kappany HA (2007) Post-percutaneous nephrolithotomy extensive hemorrhage: a study of risk factors. J Urol 177(2):576–579PubMedCrossRef
3.
Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51:899–906PubMedCrossRef
4.
Tefekli A, Ali Karadag M, Tepeler K, Sari E, Berberoglu Y, Baykal M, Sarilar O, Muslumanoglu AY (2008) Classification of percutaneous nephrolithotomy complications using the modified clavien grading system: looking for a standard. Eur Urol 53(1):184–190PubMedCrossRef
5.
El-Nahas AR, Eraky I, Shokeir AA, Shoma AM, EL-Assmy AM, EL-Tabey NA, Eraky I, El-Kappany HA, El-Kenawy MR (2012) Percutaneous nephrolithotomy for treating staghorn stones: 10 years of experience of a tertiary-care centre. Arab J Urol 10:324–329CrossRef
6.
Martin X, Murat FJ, Feitosa LC, Rouvière O, Lyonnet D, Gelet A, Dubernard J (2000) Severe bleeding after nephrolithotomy: results of hyperselective embolization. Eur Urol 37(2):136–139PubMedCrossRef
7.
Duvdevani M, Razvi H, Sofer M, Beiko DT, Nott L, Chew BH, Denstedt JD (2007) Third prize: contemporary percutaneous nephrolithotripsy: 1585 procedures in 1338 consecutive patients. J Endourol 21(8):824–829PubMedCrossRef
8.
Kukreja R, Desai M, Patel S, Bapat S, Desai M (2004) Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol 18:715–722PubMedCrossRef
9.
Lewis S, Patel U (2004) Major complications after percutaneous nephrostomy-lessons from a department audit. Clin Radiol 59:171–179PubMedCrossRef
10.
Cadeddu JA, Arrindell D, Moore RG (1997) Near fatal air embolism during percutaneous nephrostomy placement. J Urol 158:1519PubMedCrossRef
Metadata
Title
Calcular pulmonary embolism
Authors
Mohamed H. Zahran
Yasser Osman
Tarek EL-Diasty
Publication date
01-04-2014
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0573-1

Other articles of this Issue 4/2014

International Urology and Nephrology 4/2014 Go to the issue

Urology - Original Paper

External extension of double-J ureteral stent during pyeloplasty: inexpensive stent and non-cystoscopic removal

Urology - Original Paper

A comparative study on the use of tamsulosin versus alfuzosin in spontaneous micturition recovery after transurethral catheter removal in patients with benign prostatic growth

Nephrology - Original Paper

Perirenal fat associated with microalbuminuria in obese rats

Nephrology - Original Paper

Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study

Urology - Original Paper

Predictive factors for the development of chronic renal insufficiency after renal surgery: a multicenter study

Nephrology - Original Paper

Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits